Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Pediatric Ophthalmology

Can Congenital Toxoplasmosis Cause Late-Onset Eye Problems?

At a Glance

Yes, children treated for congenital toxoplasmosis can still develop late-onset eye problems. The parasite forms dormant cysts in the retina that can reactivate years later and cause inflammation. Annual dilated eye exams are essential to catch and treat these reactivations early to preserve vision.

Yes, even if your baby is completely healthy and finishes their full 12-month treatment protocol, there is still a chance they could develop eye problems later in childhood or adolescence [1][2]. While completing the first year of treatment—especially when started in the first few months of life—dramatically lowers the risk and severity of future complications [1], it does not completely eliminate the risk of new eye lesions forming over time [3].

(Note: This page focuses specifically on late-onset vision risks. Other sections of this guide cover neurological and developmental monitoring).

Why Do Eye Problems Happen Later?

The parasite that causes toxoplasmosis (Toxoplasma gondii) has different life stages. The year-long antibiotic treatment your infant receives is highly effective at clearing the active, rapidly dividing form of the parasite [4][5].

However, the parasite is also capable of forming dormant, microscopic cysts (known as bradyzoites) in the tissues of the eye, specifically the retina [6]. The standard medications used in the infant treatment protocol cannot completely eliminate these sleeping cysts [5]. Usually, your child’s healthy immune system keeps these cysts dormant and harmless. But years later, for reasons that are not always understood (though sometimes linked to physical trauma to the eye), a dormant cyst can wake up or “reactivate” [6][7]. When this happens, it causes an inflammatory response in the eye, known as retinochoroiditis, which can lead to new areas of scarring in the retina [8].

Symptoms to Watch For in Older Children

If a cyst reactivates, it creates a new area of inflammation in the back of the eye [8]. Because more than 80% of these lesions can happen in the outer edges (periphery) of the retina, a child might not notice any symptoms at all [9].

When symptoms do occur, they depend on exactly where the inflammation is located and can include:

  • New “floaters”: Small dark spots, specks, or cobwebs that drift across their field of vision [10].
  • Blurred or decreased vision: Trouble seeing clearly, or sudden changes in visual sharpness [10].
  • Eye redness and pain: Inflammation inside the eye (uveitis) can make the eye look red and feel achy [8].

A note on younger children: For toddlers and preschoolers who cannot accurately describe floaters or blurry vision, watch for behavioral signs. These can include newly developed squinting, holding objects very close to their face, or frequently rubbing or covering one eye.

The Importance of Long-Term Eye Exams

Because late-onset vision problems are a lifelong possibility, completing the infant treatment protocol is only the first step in protecting your child’s sight [1]. Ongoing, regular follow-up with a pediatric ophthalmologist (a doctor who specializes in children’s eyes) is critical [2].

Medical experts generally recommend that children who were treated for congenital toxoplasmosis receive a comprehensive dilated eye exam at least once a year throughout childhood and adolescence [1][11]. The dilating eye drops allow the doctor to look at the very back of the eye to catch any new, asymptomatic lesions early [9].

If your child ever reports sudden visual changes between annual exams, they should be evaluated by their eye doctor immediately [10]. If a reactivation is found, try not to panic. The treatment for a reactivated cyst is typically much shorter than the infant protocol (often lasting just a few weeks) and is highly effective at stopping the inflammation and preserving vision when caught early [5].

Common questions in this guide

Why do eye problems happen years after toxoplasmosis treatment?
The parasite that causes toxoplasmosis can form dormant, microscopic cysts in the retina. While infant treatment effectively clears active parasites, it cannot eliminate these sleeping cysts. For reasons not fully understood, these cysts can wake up years later and cause inflammation in the eye.
What symptoms of eye cyst reactivation should I watch for in my child?
Watch for new floaters (dark spots or cobwebs), blurred or decreased vision, and eye redness or pain. In toddlers and preschoolers who cannot accurately describe vision changes, watch for behavioral signs like newly developed squinting, holding objects very close to their face, or frequently rubbing one eye.
How often should my child see a pediatric ophthalmologist?
Medical experts strongly recommend that children who were treated for congenital toxoplasmosis receive a comprehensive dilated eye exam at least once a year throughout childhood and adolescence. This allows the doctor to check the back of the eye for any new, asymptomatic lesions.
What happens if a dormant toxoplasmosis eye cyst reactivates?
If a cyst reactivates, it causes an inflammatory response in the eye known as retinochoroiditis. Treatment is typically a short course of medication lasting just a few weeks. When caught early, this short-term treatment is highly effective at stopping the inflammation and preserving vision.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What schedule do you recommend for my child's follow-up dilated eye exams as they grow?
  2. 2.Are there any specific sports or activities where my child should wear protective eyewear to prevent eye trauma?
  3. 3.If my child complains of sudden vision changes like floaters, what is the best way to get them evaluated urgently by your office?
  4. 4.Did you see any dormant scars on my baby's most recent eye exam, and where exactly are they located?
  5. 5.What are the standard, short-term treatment options if an eye cyst does reactivate in the future?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Ocular Outcome of Brazilian Patients With Congenital Toxoplasmosis.

    Lago EG, Endres MM, Scheeren MFDC, Fiori HH

    The Pediatric infectious disease journal 2021; (40(1)):e21-e27 doi:10.1097/INF.0000000000002931.

    PMID: 33060522
  2. 2

    Late diagnosis of congenital toxoplasmosis based on serological follow-up: A case report.

    Dard C, Chemla C, Fricker-Hidalgo H, et al.

    Parasitology international 2017; (66(2)):186-189 doi:10.1016/j.parint.2016.12.004.

    PMID: 27956093
  3. 3

    Intravitreal Clindamycin as an Adjuvant Therapy in Congenital Toxoplasma Retinochoroiditis in a Neonate - A Case Report.

    Upadhyaya A, Jalali S, Tyagi M, Parameswarappa DC

    Ocular immunology and inflammation 2024; (32(6)):1101-1104 doi:10.1080/09273948.2023.2171890.

    PMID: 36758215
  4. 4

    One severe case of congenital toxoplasmosis in China with good response to azithromycin.

    Li J, Zhao J, Yang X, et al.

    BMC infectious diseases 2021; (21(1)):920 doi:10.1186/s12879-021-06619-1.

    PMID: 34488656
  5. 5

    Recurrence of Ocular Toxoplasmosis after Vitrectomy: Case Report and Review.

    Souza GM, de Souza CE, Passos RM, et al.

    Ocular immunology and inflammation 2023; (31(2)):416-420 doi:10.1080/09273948.2022.2026408.

    PMID: 35081011
  6. 6

    Association Between Ocular Trauma and Activation of Ocular Toxoplasmosis.

    Inchauspe S, Palacio A, Arriazu G, et al.

    Ocular immunology and inflammation 2024; (32(6)):1065-1069 doi:10.1080/09273948.2023.2203215.

    PMID: 37134295
  7. 7

    Toxoplasmic retinochoroiditis: The influence of age, number of retinochoroidal lesions and genetic polymorphism for IFN-γ +874 T/A as risk factors for recurrence in a survival analysis.

    Aleixo ALQDC, Vasconcelos C de Oliveira R, Cavalcanti Albuquerque M, et al.

    PloS one 2019; (14(2)):e0211627 doi:10.1371/journal.pone.0211627.

    PMID: 30753197
  8. 8

    Multimodal Imaging in Ocular Toxoplasmosis.

    Brandão-de-Resende C, Balasundaram MB, Narain S, et al.

    Ocular immunology and inflammation 2020; (28(8)):1196-1204 doi:10.1080/09273948.2020.1737142.

    PMID: 32160073
  9. 9

    [Ocular toxoplasmosis in infants 0 to 12 months of age with congenital toxoplasmosis].

    González V L, Cardozo S O, Samudio A M, Mesquita R M

    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 2022; (39(3)):265-272 doi:10.4067/s0716-10182022000200265.

    PMID: 36156688
  10. 10

    [Epidemiology and clinical pattern of ocular toxoplasmosis in Kinshasa].

    Nsiangani Lusambo N, Kaimbo Wa Kaimbo D

    Journal francais d'ophtalmologie 2019; (42(8)):900-906 doi:10.1016/j.jfo.2019.05.017.

    PMID: 31248609
  11. 11

    Diagnosis and treatment of congenital toxoplasmosis: an updated overview.

    Nguyen TG, Garnaud C, Brenier-Pinchart MP, Robert MG

    Expert review of anti-infective therapy 2026; (24(5)):501-516 doi:10.1080/14787210.2026.2673215.

    PMID: 42108950

This page provides educational information about late-onset eye risks in congenital toxoplasmosis. It does not replace professional medical advice, diagnosis, or treatment from your child's pediatric ophthalmologist.

Get notified when new evidence is published on Congenital toxoplasmosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.